Search

Your search keyword '"Moore, Katrina"' showing total 349 results

Search Constraints

Start Over You searched for: Author "Moore, Katrina" Remove constraint Author: "Moore, Katrina"
349 results on '"Moore, Katrina"'

Search Results

6. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

7. Evaluating the presymptomatic time window in genetic Frontotemporal Dementia

8. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

9. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

11. INTRODUCTION

13. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

14. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

16. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

19. Differential early subcortical involvement in genetic FTD within the GENFI cohort

20. Disease-related cortical thinning in presymptomatic granulin mutation carriers

21. Assessing breast cancer risk: Tailored surveillance and risk-reductive interventions.

23. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

26. The Dementias Platform UK (DPUK) Data Portal

27. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

28. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

30. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study

34. INTRODUCTION

35. CONCLUSION.

36. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

37. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

38. Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling

39. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

40. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

41. The Transformation of Black Music: The Rhythms, the Songs, and the Ships of the African Diaspora

43. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort

44. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort

45. Ventricular volume expansion in presymptomatic genetic frontotemporal dementia

46. Assessing breast cancer risk: Tailored surveillance and risk-reductive interventions.

49. An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers

50. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Catalog

Books, media, physical & digital resources